Showing results (1221-1230 of 4,540) with videos related to
Sort By:
Pageof 454
Journal of Gastroenterology|September 8, 2019
Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphomaEri Ishikawa, Masanao Nakamura, Kazuyuki Shimada, et al.Journal of Gastroenterology|September 9, 2019
Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancersYuji Eso, Takahiro Shimizu, Haruhiko Takeda, et al.Journal of Gastroenterology|January 15, 2022
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agentsYuya Seko, Michihisa Moriguchi, Aya Takahashi, et al.Journal of Gastroenterology|January 16, 2022
Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potentialChihiro Takeuchi, Junichi Sato, Satoshi Yamashita, et al.Journal of Gastroenterology|May 7, 2008
Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over studyYasumasa Niwa, Masanao Nakamura, Naoki Ohmiya, et al.Journal of Gastroenterology|May 7, 2008
Decreased numbers of FoxP3-positive and TLR-2-positive cells in intestinal mucosa are associated with improvement in patients with active inflammatory bowel disease following selective leukocyte apheresisVladislaw Muratov, Ann-Kristin Ulfgren, Marianne Engström, et al.Journal of Gastroenterology|February 18, 2014
Accommodation in a refugee shelter as a risk factor for peptic ulcer bleeding after the Great East Japan Earthquake: a case-control study of 329 patientsTakeshi Kanno, Kastunori Iijima, Tomoyuki Koike, et al.Journal of Gastroenterology|March 24, 2021
The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysisYuki Hayashi, Kohei Wagatsuma, Masanori Nojima, et al.Journal of Gastroenterology|August 17, 2011
Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validationHiroki Nishikawa, Tadashi Inuzuka, Haruhiko Takeda, et al.Journal of Gastroenterology|August 18, 2011
Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individualsHiroyuki MatsubayashiPageof 454